SYRS vs BIIB: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Biogen Inc in 2026
SYRS
Syros Pharmaceuticals Inc
$0.00
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | SYRS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | -0.0% | -0.1% | SYRS |
| Gross Margin | -22863.0% | 78.9% | BIIB |
Analyze SYRS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or BIIB a better investment?
Comparing SYRS and BIIB: Syros Pharmaceuticals Inc has a market cap of $0.01M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and BIIB?
SYRS (Syros Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or BIIB?
SYRS has higher revenue growth at -0.0% vs -0.1% for BIIB.
Which company is more profitable: SYRS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -22863.0% for SYRS.
Which is the larger company: SYRS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $0.01M for SYRS.
Should I buy SYRS or BIIB in 2026?
Both SYRS and BIIB have investment merit. SYRS trades at $0.00 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and BIIB stock?
Key differences: Market Cap ($0.01M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (-0.0% vs -0.1%), Gross Margin (-22863.0% vs 78.9%).